Bremelanotide was developed from the peptide hormone Melanotan II. In initial testing, Melanotan II did induce tanning but additionally caused sexual arousal and spontaneous erections as unexpected side effects in nine out of the ten original male volunteer test subjects (Ref: Uni of Arizona Dr Hunter Wells) Further testing showed Bremelanotide to induce lordosis and was also effective in treating sexual dysfunction in both men (erectile dysfunction or impotence) and women (sexual arousal disorder). Unlike Viagra and other related medications, it does not act upon the vascular system but directly increases sexual desire via the nervous system.

Fortunately, there now is a safe and efficacious alternative for clinicians wishing to treat male or female sexual dysfunction – the peptide PT-141 (bremelanotide)  

  • Increase sexual frequency.
  • Boost sex drive.
  • Treatment for men and women with hypo-active sexual desire disorder.
  • Raise sexual desire.
  • Increase female sexual function index total score and female sexual distress scale-desire/arousal/orgasm total